The risk of developing irritable bowel syndrome (IBS) is greater among people who weighed less than 1,500 g at birth compared to those who weighed more than 1,500 g, and patients with a lower birthweight tend to develop the condition earlier than their heavier counterparts, according to study findings published online Sept. 28 in Gut.
The risk of developing irritable bowel syndrome (IBS) is greater among people who weighed less than 1,500 g at birth compared to those who weighed more than 1,500 g, and patients with a lower birthweight tend to develop the condition earlier than their heavier counterparts, according to study findings published online Sept. 28 in Gut.
Jennifer R. Harris, PhD, of the Norwegian Institute of Public Health in Oslo, Norway, and colleagues conducted a postal questionnaire of 12,700 Norwegian twins born in the 1960s and 1970s, with a 31-item checklist of illnesses and symptoms including IBS. In order to test the association between intrauterine growth and IBS, the investigators analyzed data from discordant monozygotic pairs.
Among the monozygotic pairs, there was 22.4% concordance with IBS, versus only 9.1% among dizygotic twins. After adjustment, subjects with low birthweight (below 1,500 g) were 2.4 times more likely to have IBS than those with a heavier birthweight. The symptoms developed 7.7 years earlier in subjects with low birthweight compared to those patients with higher birthweight.
Bengtson M-B, Ronning T, Vatn M, et al. IBS in twins: genes and environment. Gut. Published Online First: 28 September 2006. doi:10.1136/gut.2006.097287.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
No link found between prenatal cannabis use and childhood developmental delay
November 5th 2024In a recent study, offspring of women with cannabis use in early pregnancy confirmed by self-report or toxicology test were not at an increased risk of childhood early developmental delay up to the age of 5.5 years.
Read More
Prenatal cannabis use not linked to offspring ASD development
November 1st 2024In a recent study, adjustments for maternal characteristics mediated the association between maternal prenatal cannabis use and offspring autism spectrum disorder, indicating no statistically significant increase in risk.
Read More
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More